See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311241_2014_Intermolecular_INC.pdf
Logs
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001311241')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001311241, Intermolecular INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 13,956,000 |
| 1 | LiabilitiesNonCurrent | 0 |
| 2 | remainder_Liabilities | 25,674,000 |
| 3 | AssetsCurrent | 81,352,000 |
| 4 | AssetsNonCurrent | 280,000 |
| 5 | IntangibleAssets | 7,855,000 |
| 6 | PropertyPlantAndEquipmentNet | 28,485,000 |
| 7 | remainder_Assets | 6,510,000 |
| 8 | ResearchAndDevelopmentExpense | 24,502,000 |
| 9 | SellingGeneralAndAdministrativeExpense | 18,448,000 |
| 10 | AmortizationOfIntangibleAssets | 0 |
| 11 | remainder_Expenses | 32,502,000 |
| 12 | remainder_Revenues | 67,406,000 |
| 13 | remainder_NetIncome | -773,000 |
| 14 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 39,630,000 |
| 1 | Assets | 124,482,000 |
| 2 | Expenses | 75,452,000 |
| 3 | Revenues | 67,406,000 |
| 4 | StockholdersEquity | 84,852,000 |
| 5 | NetIncome | -8,819,000 |
| 6 | ComprehensiveNetIncome | -8,819,000 |
| 7 | BaseVar | 357,109,365 |
| 8 | EconomicCapitalRatio | 2.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
